ATE291587T1 - Somatostatin analoge und deren verwendung zur behandlung von krebs - Google Patents

Somatostatin analoge und deren verwendung zur behandlung von krebs

Info

Publication number
ATE291587T1
ATE291587T1 AT00952332T AT00952332T ATE291587T1 AT E291587 T1 ATE291587 T1 AT E291587T1 AT 00952332 T AT00952332 T AT 00952332T AT 00952332 T AT00952332 T AT 00952332T AT E291587 T1 ATE291587 T1 AT E291587T1
Authority
AT
Austria
Prior art keywords
cancer
treatment
peptides
somatostatin
agonists
Prior art date
Application number
AT00952332T
Other languages
English (en)
Inventor
Anand C Burman
Sudhanand Prasad
Rama Mukherjee
Manu Jaggi
Anu T Singh
Archna Mathur
Original Assignee
Dabur Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Res Foundation filed Critical Dabur Res Foundation
Application granted granted Critical
Publication of ATE291587T1 publication Critical patent/ATE291587T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT00952332T 2000-07-31 2000-07-31 Somatostatin analoge und deren verwendung zur behandlung von krebs ATE291587T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/020872 WO2002010215A1 (en) 2000-07-31 2000-07-31 Somatostatin analogs for the treatment of cancer

Publications (1)

Publication Number Publication Date
ATE291587T1 true ATE291587T1 (de) 2005-04-15

Family

ID=21741640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952332T ATE291587T1 (de) 2000-07-31 2000-07-31 Somatostatin analoge und deren verwendung zur behandlung von krebs

Country Status (6)

Country Link
EP (1) EP1198478B1 (de)
AT (1) ATE291587T1 (de)
AU (1) AU2000265052A1 (de)
CA (1) CA2385910A1 (de)
DE (1) DE60018937T2 (de)
WO (1) WO2002010215A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189856B2 (en) 2001-12-28 2007-03-13 Gideon Shapiro Non-peptide somatostatin receptor ligands
WO2004093807A2 (en) 2003-04-22 2004-11-04 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin vectors
CN103501823B (zh) 2011-02-17 2018-05-04 杜兰教育基金委员会 多组分组合物以及它们的用途
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物
CN104768565B (zh) 2012-11-01 2017-04-26 益普生制药股份有限公司 促生长素抑制素类似物及其二聚体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH679045A5 (de) * 1987-06-29 1991-12-13 Sandoz Ag

Also Published As

Publication number Publication date
DE60018937D1 (de) 2005-04-28
WO2002010215A1 (en) 2002-02-07
EP1198478B1 (de) 2005-03-23
EP1198478A1 (de) 2002-04-24
CA2385910A1 (en) 2002-02-07
DE60018937T2 (de) 2006-03-30
AU2000265052A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
IL232501A (en) Peptide or polypeptide-resistant protein analogs and their uses
CO5700784A2 (es) Polipeptidos de virus de papiloma humano y composiciones in- munogenas
UA103154C2 (uk) Hla-a*1101-обмежений пептид wt1 і фармацевтична композиція, яка містить його
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
ES2190653T3 (es) Productos de reaccion del acido hialuronico y de aminoacidos naturales y su utilizacion en composiciones cosmeticas y farmaceuticas.
RS54215B1 (en) COMPOSITIONS AND PROCEDURES FOR DIAGNOSIS AND TREATMENT OF CANCER
CO4970837A1 (es) Inhibidores de captesina de nitrilo de dipeptido .
NO20040222L (no) Peptider til fjerning eller destruksjon av celler
EP3533461A3 (de) Von prame abstammende peptide und immunogene zusammensetzungen damit
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
HRP20050585A2 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
ATE367815T1 (de) Verwendung von einem vasopressin-antagonisten wie conivaptan zur herstellung eines medikaments für die behandlung der pulmonalen hypertension
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
ATE282607T1 (de) Tryptase-inhibitoren
MY147920A (en) Antibacterial and antiviral peptides from actinomadura namibiensis
DE60018937D1 (de) Somatostatin analoge und deren verwendung zur behandlung von krebs
HUP0400976A2 (hu) VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek
MY126118A (en) Somatostatin analogs for the treatment of cancer
DE69831257D1 (de) Histogranin peptide und deren analgetische verwendung
DE50312414D1 (de) Kompositmaterialien aus calciumverbindungen und glucuronsäurehaltigen polysacchariden
RS52448B (en) ANTITUMOR PHARMACEUTICAL COMPOSITION CONTAINING SERALIZIN POLYPEPTIDE FRAGMENTS
AU6011001A (en) Novel lhrh-antagonists, production and use thereof as medicament

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties